Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain

AbstractWith less than 50% of patients responding to the current standard of care and poor efficacy and selectivity of current treatments, neuropathic pain continues to be an area of considerable unmet medical need. Biological therapeutics such as monoclonal antibodies (mAbs) provide better intrinsi